Vabanesi, Marco
Pisa, Marco
Guerrieri, Simone
Moiola, Lucia
Radaelli, Marta
Medaglini, Stefania
Martinelli, Vittorio
Comi, Giancarlo
Leocani, Letizia
Article History
Received: 20 February 2019
Accepted: 24 June 2019
First Online: 17 July 2019
Competing Interests
: Dr. Vabanesi, Pisa, Guerrieri, Radaelli, Medaglini declare no competing interests relevant to the manuscript. Dr. Moiola received honoraria for speaking in scientific meetings and for advisory board from Biogen, Teva, Sanofi-Genzyme and Merck. Dr. Martinelli received honoraria for consulting services or speaking activity from Biogen, Merck, Novartis, Teva, Almirall, and Sanofi-Genzyme. Prof. Comi received personal compensation for consulting services and/or speaking activities from Novartis, Teva, Sanofi, Sanofi-Genzyme, Merck, Biogen, Excemed, Serono Symposia International Foundation, Roche, Almirall, Receptos, Celgene, and Forward Pharma. Prof. Leocani received honoraria for consulting services and/or speaking activity from Biogen, Novartis and Excemed.